Prof. Buno Bonetti MD, PhD
Neurology Unit
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy

The scientific career of Dr. Bonetti has been always devoted to the clinical and experimental aspects of neuroimmunology. From 1988 to 1995 he worked on the pathogenic aspects of dysimmune neuropathies, particularly those associated with antibodies with anti-nerve activity.

In 1993-94, as Scholar Research he was at the Department of Neuroanatomy, Institute Max-Plank for Psychiatry, Munich, Germany, to study the role of growth factors in autoimmune diseases.

In 1995-96 he worked as Research Fellow with Prof. Raine at the Albert Einstein College of Medicine, Yeshiva University, New York, on the molecular aspects of multiple sclerosis pathogenesis, focusing on cytokines and oligodendrocyte cytotoxicity.

He came back to Italy in 1997 where he continued to work on the pathogenesis of autoimmune diseases of the central nervous system, applying proteomics and cell-based-techniques. He then focused his attention to mesenchymal stem cells and their extracellular vesicles; in both cases, he was concentrated on their potential applications in neurogical diseases (including multiple sclerosis, amyotrophic lateral sclerosis), due to their immune suppressive capabilities. Since 2017, he is the Head of the Neurology Unit in Azienda Ospedaliera Universitaria Integrata of Verona. He is still active in the Laboratory of Neuropathology and collaborating with Raffaella Mariotti (Anatomy) and Gabriela Constantin (Pathology) of the University of Verona.

Referee activity: Journal of Neuroimmunology, Journal of Neuropathology and Experimental Neurology, Neurological Sciences, Journal of the Peripheral Nervous System, Brain Research Bullettin, Cellular and Molecular Life Sciences, Proteomics, Trends in Immunology, Cellular and Molecular Neurobiology, Cell Transplantation, Expert Review of Clinical Immunology, Neuroscience Letters, Journal of Neurological Sciences, Annals of Neurology, Neurology, Stem cells International e Plos One.